中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
9期
1349-1350,后插1
,共3页
血管瘤%儿童%面部
血管瘤%兒童%麵部
혈관류%인동%면부
Hemangioma%Child%Face
目的 分析平阳霉素联合地塞米松治疗儿童颌面部血管瘤的效果.方法 对126例颌面部血管瘤患者分别采用平阳霉素联合地塞米松治疗(观察组)74例,平阳霉素治疗(对照组)52例,观察两组治疗效果和不良反应.结果 观察组痊愈率为85.13%,对照组痊愈率为34.61%,两组差异有统计学意义(P<0.05);两组患者不良反应发生率,差异无统计学意义(P>0.05).结论 平阳霉素联合地塞米松注射治疗儿童颌面部血管瘤,其疗效确切,操作简单,值得向临床广泛推荐和应用.
目的 分析平暘黴素聯閤地塞米鬆治療兒童頜麵部血管瘤的效果.方法 對126例頜麵部血管瘤患者分彆採用平暘黴素聯閤地塞米鬆治療(觀察組)74例,平暘黴素治療(對照組)52例,觀察兩組治療效果和不良反應.結果 觀察組痊愈率為85.13%,對照組痊愈率為34.61%,兩組差異有統計學意義(P<0.05);兩組患者不良反應髮生率,差異無統計學意義(P>0.05).結論 平暘黴素聯閤地塞米鬆註射治療兒童頜麵部血管瘤,其療效確切,操作簡單,值得嚮臨床廣汎推薦和應用.
목적 분석평양매소연합지새미송치료인동합면부혈관류적효과.방법 대126례합면부혈관류환자분별채용평양매소연합지새미송치료(관찰조)74례,평양매소치료(대조조)52례,관찰량조치료효과화불량반응.결과 관찰조전유솔위85.13%,대조조전유솔위34.61%,량조차이유통계학의의(P<0.05);량조환자불량반응발생솔,차이무통계학의의(P>0.05).결론 평양매소연합지새미송주사치료인동합면부혈관류,기료효학절,조작간단,치득향림상엄범추천화응용.
Objective To analyze and summarize the effects of pingyangmycin (PYM) combined with dexamethasone in the treatment of children with oral and maxillofacial hemangioma.Methods Clinical data of 126 patients with maxillofacial hemangioma were retrospectively analyzed.74 patients were treated with PYM combined with dexamethasone(observation group),52 patients were treated with PYM(control group).The therapeutic effects and adverse reactions were observed in two groups.Results After treatment,the cure rate of observation group was 85.13%,which was higher than control group(34.61%),and the difference was statistically significant(P < 0.05).The incidence rate of adverse reactions of the two groups was similar,and the difference was not statistically significant (P > 0.05).Conclusion PYM combined with dexamethasone in the treatment of children with maxillofacial hemangioma has good efficacy and low incidence rate of adverse reactions,and it is worth widely recommended and applied in clinic.